Insider Trading - Oncotelic Therapeutics Inc. (OTLC)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Oncotelic Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-12-16
Purchase
2016-12-20
4:15 pm
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
30,000 $0.34742 $10,423 30,000
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:22 pm
MATEON THERAPEUTICS INC MATN LOAR MATTHEW M
CFO
250,000 $0 $0 300,000
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:23 pm
MATEON THERAPEUTICS INC MATN Schwieterman William D
CEO
625,000 $0 $0 625,747
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:24 pm
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
250,000 $0 $0 280,000
(Direct)
View
2020-03-26
Purchase
2020-03-27
5:49 pm
MATEON THERAPEUTICS INC MATN Trieu Vuong
CEO
3,000 $0.12 $360 15,761,808
(Indirect
Direct)
View
2020-11-19
Purchase
2020-11-23
3:01 pm
MATEON THERAPEUTICS INC MATN Trieu Vuong
CEO
50,500 $0.19 $9,595 15,812,308
(Indirect
Direct)
View
2020-11-19
Purchase
2020-11-23
3:01 pm
MATEON THERAPEUTICS INC MATN Park Chulho
CTO
22,173 $0.1848 $4,098 2,833,992
(Direct)
View
2020-11-20
Purchase
2020-11-24
5:30 pm
MATEON THERAPEUTICS INC MATN Shah Amit B.
CFO
60,000 $0.19264 $11,558 60,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-10-25
Option Award
2016-10-27
4:24 pm
N/A
2022-10-25
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
135,612 $0 135,612
(Direct)
View
2016-10-25
Option Award
2016-10-27
4:28 pm
N/A
2022-10-25
MATEON THERAPEUTICS INC MATN SANDAGE BOBBY W PHD
Director
135,612 $0 135,612
(Direct)
View
2017-01-12
Option Award
2017-01-13
5:01 pm
N/A
2027-01-12
MATEON THERAPEUTICS INC MATN CHAPLIN DAVID
Chief Scientific Officer
262,500 $0.375 262,500
(Direct)
View
2017-01-12
Option Award
2017-01-13
5:01 pm
N/A
2027-01-12
MATEON THERAPEUTICS INC MATN LOAR MATTHEW M
CFO
350,000 $0.375 350,000
(Direct)
View
2017-01-12
Option Award
2017-01-13
5:02 pm
N/A
2027-01-12
MATEON THERAPEUTICS INC MATN Schwieterman William D
CEO
550,000 $0.375 550,000
(Direct)
View
2017-06-09
Option Award
2017-06-12
8:29 pm
N/A
2023-06-09
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
121,483 $0 121,483
(Direct)
View
2017-06-09
Option Award
2017-06-12
8:30 pm
N/A
2023-06-09
MATEON THERAPEUTICS INC MATN SANDAGE BOBBY W. JR. PHD.
Director
121,483 $0 121,483
(Direct)
View
2017-06-09
Option Award
2017-06-12
8:31 pm
N/A
2023-06-09
MATEON THERAPEUTICS INC MATN Pedder Simon
Director
121,483 $0 121,483
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:22 pm
2018-04-12
2020-04-12
MATEON THERAPEUTICS INC MATN LOAR MATTHEW M
CFO
125,000 $0 125,000
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:22 pm
N/A
N/A
MATEON THERAPEUTICS INC MATN LOAR MATTHEW M
CFO
125,000 $0 125,000
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:23 pm
2018-04-12
2020-04-12
MATEON THERAPEUTICS INC MATN Schwieterman William D
CEO
312,500 $0 312,500
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:23 pm
N/A
N/A
MATEON THERAPEUTICS INC MATN Schwieterman William D
CEO
312,500 $0 312,500
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:24 pm
2018-04-12
2020-04-12
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
125,000 $0 125,000
(Direct)
View
2018-04-12
Purchase
2018-04-16
4:24 pm
N/A
N/A
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
125,000 $0 125,000
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:12 pm
N/A
2024-06-20
MATEON THERAPEUTICS INC MATN CHAPLIN DAVID
Director
258,171 $0 258,171
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:12 pm
N/A
2028-06-20
MATEON THERAPEUTICS INC MATN LOAR MATTHEW M
CFO
250,000 $0 250,000
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:12 pm
N/A
2028-06-20
MATEON THERAPEUTICS INC MATN LOAR MATTHEW M
CFO
500,000 $0 500,000
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:13 pm
N/A
2024-06-20
MATEON THERAPEUTICS INC MATN Pedder Simon
Director
258,171 $0 258,171
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:15 pm
N/A
2024-06-20
MATEON THERAPEUTICS INC MATN Reynolds Donald Rogers
Director
258,171 $0 258,171
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:16 pm
N/A
2024-06-20
MATEON THERAPEUTICS INC MATN SANDAGE BOBBY W. JR. PHD.
Director
258,171 $0 258,171
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:17 pm
N/A
2028-06-20
MATEON THERAPEUTICS INC MATN Schwieterman William D
CEO
500,000 $0 500,000
(Direct)
View
2018-06-20
Option Award
2018-06-22
4:17 pm
N/A
2028-06-20
MATEON THERAPEUTICS INC MATN Schwieterman William D
CEO
500,000 $0 500,000
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:35 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Saund Saran
CHIEF BUSINESS OFFICER
16,354,961 $0 16,354,961
(Direct)
View
2021-03-31
Option Award
2021-07-16
5:35 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Saund Saran
CHIEF BUSINESS OFFICER
102,519 $0 16,457,480
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:35 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Saund Saran
CHIEF BUSINESS OFFICER
16,355 $0 0
(Direct)
View
2021-03-31
Option Award
2021-07-16
5:35 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc. OTLC Saund Saran
CHIEF BUSINESS OFFICER
216,279 $0 216,279
(Direct)
View
2021-07-08
Option Award
2021-07-16
5:36 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc. OTLC Diamond David
Director
451,467 $0 451,467
(Direct)
View
2021-07-08
Option Award
2021-07-16
5:37 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Shah Amit B.
CFO
298,837 $0 358,837
(Direct)
View
2021-07-08
Option Award
2021-07-16
5:37 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc. OTLC Shah Amit B.
CFO
698,256 $0 698,256
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:37 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director
3,291,720 $0 3,330,647
(Indirect)
View
2021-03-31
Conversion
2021-07-16
5:37 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director
3,292 $0 0
(Indirect)
View
2021-03-31
Option Award
2021-07-16
5:37 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director
357,412 $0 357,412
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
74,455,720 $0 90,268,024
(Direct)
View
2021-03-31
Option Award
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
259,302 $0 90,527,320
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
13,849,161 $0 16,780,384
(Indirect)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
5,672,025 $0 6,872,529
(Indirect)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
74,456 $0 0
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
13,849 $0 0
(Indirect)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
5,672 $0 0
(Indirect)
View
2021-03-31
Option Award
2021-07-16
5:38 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
Chairman
10% Owner
513,953 $0 513,953
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:39 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
CHIEF CLINICAL OFFICER
938,646 $0 1,137,314
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:39 pm
N/A
N/A
Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
CHIEF CLINICAL OFFICER
938 $0 0
(Direct)
View
2021-03-31
Option Award
2021-07-16
5:39 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
CHIEF CLINICAL OFFICER
400,000 $0 400,000
(Direct)
View
2021-09-03
Option Award
2021-09-08
5:00 pm
N/A
2031-09-03
Oncotelic Therapeutics Inc. OTLC Saund Saran
Chief Business Officer
675,000 $0 675,000
(Direct)
View
2021-09-03
Option Award
2021-09-08
5:00 pm
N/A
2031-09-03
Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director
500,000 $0 500,000
(Direct)
View
2021-09-03
Option Award
2021-09-08
5:00 pm
N/A
2031-09-03
Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
COO
600,000 $0 600,000
(Direct)
View
2021-09-03
Option Award
2021-09-08
5:00 pm
N/A
2031-09-03
Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CEO
225,000 $0 225,000
(Direct)
View